Quest Diagnostics Incorporated updated earnings guidance for the full year of 2024. For the year, the company expects net revenues to be between $9.40 billion to $9.48 billion, Net revenues increase to be between 1.6% to 2.5%, Reported diluted EPS to be between $7.57 to $7.82 compared to the previous guidance of net revenues to be between $9.35 billion to $9.45 billion, Net revenues increase to be between 1.1% to 2.1%, Reported diluted EPS to be between $7.69 to $7.99.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
142.4 USD | +1.17% | +3.09% | +3.30% |
May. 16 | Everlasting momentum | |
May. 16 | Argus Research Adjusts Quest Diagnostics Price Target to $215 From $163 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.30% | 15.82B | |
+19.22% | 84.52B | |
-27.14% | 72.21B | |
+4.65% | 27.74B | |
-6.23% | 17.97B | |
+1.07% | 17.46B | |
+7.44% | 13.55B | |
+6.35% | 13.31B | |
+73.32% | 13.32B | |
+69.26% | 12.5B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024